A Flurry of Changes for Plan Sponsors, Prescription Drug Plans and Health Plan Vendors

Reinhart Boerner Van Deuren S.C.

Reinhart shareholders John Barlament and Katie Kratcha recently hosted a webinar in which they reviewed a number of legal and regulatory developments impacting plan sponsors, prescription drug plans and health plan vendors. Of these developments, there are four that plan sponsors and health plan vendors should monitor. Some of the effective dates and impacts are immediate, while others will play out over the next few years.

Click the video above to view the webinar, and click here if you would like to review the slides covered in the session.

Topics Discussed

• TrumpRx website
• Federal Trade Commission (FTC) settlement with Express Scripts, Inc.
• Consolidated Appropriations Act (CAA) 2026 Changes
• Proposed pharmacy benefit manager (PBM) compensation disclosure regulations

About Our Speakers

John Barlament is a shareholder in Reinhart's Employee Benefits Practice.

Katie Kratcha is a shareholder in Reinhart's Employee Benefits Practice.

More Information, How to Register